Patterns of Lisdexamfetamine Dimesylate Use in Children, Adolescents, and Adults with Attention-Deficit/Hyperactivity Disorder in Europe-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Patterns of Lisdexamfetamine Dimesylate Use in Children, Adolescents, and Adults with Attention-Deficit/Hyperactivity Disorder in Europe

Published:2020-09-01 Issue:7 Volume:30 Page:439-447
ISSN:1044-5463
Container-title:Journal of Child and Adolescent Psychopharmacology
language:en
Short-container-title:Journal of Child and Adolescent Psychopharmacology

Author:

Siffel Csaba¹²,Page Matthew³,Maxwell Tricia³,Thun Barbara⁴,Kolb Nikolaus⁴,Rosenlund Mats⁵⁶,von Bredow Dorothea⁴,Keja Jacco⁷

Affiliation:

1. Global Evidence and Outcomes, Data Sciences Institute, Shire, a Takeda Company, Lexington, Massachusetts, USA.

2. College of Allied Health Sciences, Augusta University, Augusta, Georgia, USA.

3. Marketed Products Group, Chief Medical Office, Shire, a Takeda Company, Cambridge, Massachusetts, USA.

4. Real World Solutions, IQVIA, Munich, Germany.

5. Real World Solutions, IQVIA, Solna, Sweden.

6. Department of Learning, Informatics, Management and Ethics (LIME), Karolinska Institutet, Stockholm, Sweden.

7. Real World Solutions, IQVIA, Paris, France.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Psychiatry and Mental health,Pediatrics, Perinatology and Child Health

Link

https://www.liebertpub.com/doi/pdf/10.1089/cap.2019.0173

Reference28 articles.

1. ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

2. Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder

3. Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: A Phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study

4. Stimulant Treatment Over Five Years: Adherence, Effectiveness, and Adverse Effects

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Switch to Lisdexamfetamine in the Treatment of Attention-Deficit Disorder at a Psychiatric Outpatient Clinic for School-Aged Children: A Danish Cohort Study;Journal of Child and Adolescent Psychopharmacology;2024-04-01

2. Chronic Administration of Lisdexamfetamine Induces Apoptosis and Inflammation and Reduces Sperm Quality in Adult Male Rats;Reproductive Sciences;2024-01-16

3. Therapeutic Use of Dopamine Enhancers (Stimulants);Tasman’s Psychiatry;2024

4. ADHD medication discontinuation and persistence across the lifespan: a retrospective observational study using population-based databases;The Lancet Psychiatry;2024-01

5. Attention-deficit/hyperactivity disorder medication consumption in 64 countries and regions from 2015 to 2019: a longitudinal study;eClinicalMedicine;2023-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3